These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 14569416)
41. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672 [TBL] [Abstract][Full Text] [Related]
42. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Tsutsui S; Inoue H; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S; Mori M Breast Cancer Res Treat; 2006 Aug; 98(3):261-6. PubMed ID: 16538528 [TBL] [Abstract][Full Text] [Related]
43. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339 [TBL] [Abstract][Full Text] [Related]
44. Induction of thymidine phosphorylase expression and enhancement of Furtulon sensitivity by Taxol in a human ovarian carcinoma cell line. Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K Anticancer Res; 2003; 23(3B):2665-9. PubMed ID: 12894555 [TBL] [Abstract][Full Text] [Related]
45. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938 [TBL] [Abstract][Full Text] [Related]
46. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358 [TBL] [Abstract][Full Text] [Related]
47. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935 [TBL] [Abstract][Full Text] [Related]
48. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640 [TBL] [Abstract][Full Text] [Related]
49. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A. Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463 [TBL] [Abstract][Full Text] [Related]
51. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Watanabe Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Hattori A; Tsujimoto M; Mizutani S Clin Cancer Res; 2003 Dec; 9(17):6497-503. PubMed ID: 14695154 [TBL] [Abstract][Full Text] [Related]
52. Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation. Lee YL; Liu Y; Ng PY; Lee KF; Au CL; Ng EH; Ho PC; Yeung WS Hum Reprod; 2008 Apr; 23(4):894-903. PubMed ID: 18258764 [TBL] [Abstract][Full Text] [Related]
53. Coordinated regulation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular pericytes: implications of arsenite-induced vascular dysfunction. Park JS; Seo J; Kim YO; Lee HS; Jo I Toxicology; 2009 Oct; 264(1-2):26-31. PubMed ID: 19622383 [TBL] [Abstract][Full Text] [Related]
54. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Zhang A; Meng L; Wang Q; Xi L; Chen G; Wang S; Zhou J; Lu Y; Ma D Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667 [TBL] [Abstract][Full Text] [Related]
55. The roles of vascular endothelial growth factor and angiopoietin-2 in the regression of pregnancy pyogenic granuloma. Yuan K; Lin MT Oral Dis; 2004 May; 10(3):179-85. PubMed ID: 15089929 [TBL] [Abstract][Full Text] [Related]
56. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
57. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
58. [Impact of hypoxia on taxol-induced apoptosis in human ovarian cancer cell line A2780 and its mechanism]. Huang L; Ao QL; Li F; Xing H; Lu YP; Ma D Ai Zheng; 2005 Apr; 24(4):408-13. PubMed ID: 15820061 [TBL] [Abstract][Full Text] [Related]
59. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341 [TBL] [Abstract][Full Text] [Related]
60. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]